Bioasis Technologies Stock Analysis

BiOasis Pink Sheet Analysis Notes

The company recorded a loss per share of 0.03. biOasis Technologies had not issued any dividends in recent years. Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. Bioasis Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for biOasis Technologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on biOasis Technologies please contact B FTSE at 203 533 7082 or go to https://www.bioasis.us.

biOasis Technologies Investment Alerts

BiOasis Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BiOasis Technologies's market, we take the total number of its shares issued and multiply it by BiOasis Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 1st of March, BiOasis Technologies shows the Risk Adjusted Performance of 0.109, mean deviation of 11.8, and Coefficient Of Variation of 742.02. biOasis Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm biOasis Technologies variance and maximum drawdown to decide if biOasis Technologies is priced fairly, providing market reflects its regular price of 4.0E-4 per share. As biOasis Technologies appears to be a penny stock we also recommend to validate its information ratio numbers.

biOasis Technologies Price Movement Analysis

BiOasis Technologies Outstanding Bonds

BiOasis Technologies Predictive Daily Indicators

BiOasis Technologies Forecast Models

BiOasis Technologies' time-series forecasting models are one of many BiOasis Technologies' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BiOasis Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BiOasis Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BiOasis shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BiOasis Technologies. By using and applying BiOasis Pink Sheet analysis, traders can create a robust methodology for identifying BiOasis entry and exit points for their positions.

When running BiOasis Technologies' price analysis, check to measure BiOasis Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOasis Technologies is operating at the current time. Most of BiOasis Technologies' value examination focuses on studying past and present price action to predict the probability of BiOasis Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOasis Technologies' price. Additionally, you may evaluate how the addition of BiOasis Technologies to your portfolios can decrease your overall portfolio volatility.